Emtriva Oral Capsule 200Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Emtriva: Oral capsule (200mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_1211.JPG
Emtriva 200mg Cap
Gilead Sciences Inc
Pill Identification: 200mg LOGO GILEAD 

What is this Medicine?

EMTRICITABINE (em tri SIT uh bean) is an antiretroviral medicine. It is used with other medicines to treat HIV. This medicine is not a cure for HIV. It will not stop the spread of HIV to others.

CVS Pharmacy Patient Statistics for Emtriva: Oral capsule(200mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Emtriva 200mg Capsule

NDC: 619580601
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Human Immunodeficiency Virus (HIV) Infection

Sometimes used for but not FDA approved for the following conditions:
Hepatitis B Infection, Human Immunodeficiency Virus (HIV) Prophylaxis

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Emtriva 200mg Capsule
Drug Image file DrugItem_1211.JPG
Gilead Sciences Inc
Pill Identification: 200mg LOGO GILEAD 
Shape: capsule
Color: blue,white

Reported Side Effects for Emtriva 200mg Capsule

Glycosuria Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Hives Incidence:
<30.0%*
Severity: MILD
Onset: RAPID
Infection Incidence:
<44.0%*
Severity: MILD
Onset: DELAYED
High Bilirubin Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Rash With Pustules Incidence:
<30.0%*
Severity: MILD
Onset: EARLY
Blistery Rash Incidence:
<30.0%*
Severity: MODERATE
Onset: EARLY
Vesicular Rash Incidence:
<30.0%*
Severity: MILD
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0-6.0%*
Severity: MODERATE
Onset: DELAYED
High Amylase Levels Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
2.0-23.0%*
Severity: MILD
Onset: EARLY
Low Blood Sugar Incidence:
2.0-3.0%*
Severity: MODERATE
Onset: EARLY
Increased Blood Sugar Incidence:
2.0-3.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
2.6-5.0%*
Severity: MODERATE
Onset: DELAYED
Blood In The Urine Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
3.0-5.0%*
Severity: MILD
Onset: DELAYED
Nerve Pain Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
4.0-25.0%*
Severity: MILD
Onset: EARLY
Inflamed Nerve Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Muscle Pain Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
High Triglycerides Incidence:
4.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
4.0-8.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Inability To Sleep Incidence:
5.0-16.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
5.0-6.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
6.0-22.0%*
Severity: MILD
Onset: EARLY
Depression Incidence:
6.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Skin Rash Incidence:
7.0-30.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
7.0%*
Severity: MILD
Onset: RAPID
Exfoliative Dermatitis Incidence:
7.0%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
8.0-14.0%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
8.0%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
9.0-23.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
9.0-18.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
12.0-16.0%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
12.0-20.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
14.0-28.0%*
Severity: MILD
Onset: DELAYED
Fever Incidence:
18.0%*
Severity: MILD
Onset: EARLY
High Cholesterol Incidence:
22.0%*
Severity: MODERATE
Onset: DELAYED
Darkened Skin Patches Incidence:
32.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Emtriva 200mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Marijuana and Emtriva 200mg Capsule(Emtricitabine)
Marijuana and Nucleoside reverse transcriptase inhibitors(Emtricitabine)
Although an interaction is possible, these drugs may be used together. In therory, side effects from Marijuana, Medical may get worse if you take Anti-retroviral nucleoside reverse transcriptase inhibitors (NRTIs). However, the importance of this interaction is not known. Notify your health care provider if you notice increased fatigue, nausea, vomiting, or any other unusual effects.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Emtriva

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5